These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8918742)

  • 21. CD4+ immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virus.
    Puig M; Mihalik K; Tilton JC; Williams O; Merchlinsky M; Connors M; Feinstone SM; Major ME
    Hepatology; 2006 Sep; 44(3):736-45. PubMed ID: 16941702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C vaccines: Inducing and challenging memory T cells.
    Shiina M; Rehermann B
    Hepatology; 2006 Jun; 43(6):1395-8. PubMed ID: 16729320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hepatitis C immunology].
    Alvarado Esquivel C; Leroux-Roels G
    Rev Invest Clin; 1999; 51(5):315-22. PubMed ID: 10614142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections.
    Ferrari C; Valli A; Galati L; Penna A; Scaccaglia P; Giuberti T; Schianchi C; Missale G; Marin MG; Fiaccadori F
    Hepatology; 1994 Feb; 19(2):286-95. PubMed ID: 8294086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge.
    Major ME; Mihalik K; Puig M; Rehermann B; Nascimbeni M; Rice CM; Feinstone SM
    J Virol; 2002 Jul; 76(13):6586-95. PubMed ID: 12050371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity.
    Rollier CS; Paranhos-Baccala G; Verschoor EJ; Verstrepen BE; Drexhage JA; Fagrouch Z; Berland JL; Komurian-Pradel F; Duverger B; Himoudi N; Staib C; Meyr M; Whelan M; Whelan JA; Adams VC; Larrea E; Riezu JI; Lasarte JJ; Bartosch B; Cosset FL; Spaan WJ; Diepolder HM; Pape GR; Sutter G; Inchauspe G; Heeney JL
    Hepatology; 2007 Mar; 45(3):602-13. PubMed ID: 17326154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress in the development of preventive and therapeutic vaccines for hepatitis C virus.
    Torresi J; Johnson D; Wedemeyer H
    J Hepatol; 2011 Jun; 54(6):1273-85. PubMed ID: 21236312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection.
    Shoukry NH; Grakoui A; Houghton M; Chien DY; Ghrayeb J; Reimann KA; Walker CM
    J Exp Med; 2003 Jun; 197(12):1645-55. PubMed ID: 12810686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.
    Forns X; Payette PJ; Ma X; Satterfield W; Eder G; Mushahwar IK; Govindarajan S; Davis HL; Emerson SU; Purcell RH; Bukh J
    Hepatology; 2000 Sep; 32(3):618-25. PubMed ID: 10960458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HCV-specific T-cell response in relation to viral kinetics and treatment outcome (DITTO-HCV project).
    Pilli M; Zerbini A; Penna A; Orlandini A; Lukasiewicz E; Pawlotsky JM; Zeuzem S; Schalm SW; von Wagner M; Germanidis G; Lurie Y; Esteban JI; Haagmans BL; Hezode C; Lagging M; Negro F; Homburger Y; Neumann AU; Ferrari C; Missale G;
    Gastroenterology; 2007 Oct; 133(4):1132-43. PubMed ID: 17919489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance.
    Folgori A; Spada E; Pezzanera M; Ruggeri L; Mele A; Garbuglia AR; Perrone MP; Del Porto P; Piccolella E; Cortese R; Nicosia A; Vitelli A;
    Gut; 2006 Jul; 55(7):1012-9. PubMed ID: 16484505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection.
    Bassett SE; Guerra B; Brasky K; Miskovsky E; Houghton M; Klimpel GR; Lanford RE
    Hepatology; 2001 Jun; 33(6):1479-87. PubMed ID: 11391537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune and non-immune responses to hepatitis C virus infection.
    Sun J; Rajsbaum R; Yi M
    World J Gastroenterol; 2015 Oct; 21(38):10739-48. PubMed ID: 26478666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection.
    Bain C; Parroche P; Lavergne JP; Duverger B; Vieux C; Dubois V; Komurian-Pradel F; Trépo C; Gebuhrer L; Paranhos-Baccala G; Penin F; Inchauspé G
    J Virol; 2004 Oct; 78(19):10460-9. PubMed ID: 15367612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative analysis of the immune response to DNA constructions encoding hepatitis C virus nonstructural proteins].
    Masalova OV; Lesnova EI; Ivanov AV; Pichugin AV; Permiakova KIu; Smirnova OA; Tynitskaia VL; Ulanova TI; Burkov AN; Kochetkov SN; Ataullakhanov RI; Kushch AA
    Vopr Virusol; 2013; 58(2):21-8. PubMed ID: 23785766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HCV persistence and immune evasion in the absence of memory T cell help.
    Grakoui A; Shoukry NH; Woollard DJ; Han JH; Hanson HL; Ghrayeb J; Murthy KK; Rice CM; Walker CM
    Science; 2003 Oct; 302(5645):659-62. PubMed ID: 14576438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell responses in hepatitis C: the good, the bad and the unconventional.
    Klenerman P; Thimme R
    Gut; 2012 Aug; 61(8):1226-34. PubMed ID: 21873736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques.
    Capone S; Meola A; Ercole BB; Vitelli A; Pezzanera M; Ruggeri L; Davies ME; Tafi R; Santini C; Luzzago A; Fu TM; Bett A; Colloca S; Cortese R; Nicosia A; Folgori A
    J Virol; 2006 Feb; 80(4):1688-99. PubMed ID: 16439526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis of chronic hepatitis C virus infection.
    Nelson DR; Lau JY
    Antivir Ther; 1998; 3(Suppl 3):25-35. PubMed ID: 10726053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Innate and Adaptive Immune Responses in Chronic HCV Infection.
    Dustin LB
    Curr Drug Targets; 2017; 18(7):826-843. PubMed ID: 26302811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.